-
$CTSO *CytoSorbents: CytoSorb Used Successfully to Help Treat Grade 4 Cytokine Release Syndrome Following CAR T-Cell Immunotherapy in First Published Case Report -
Today's Stock Picks
$adma$ctso$htl.v$ois$pbpb$sypr http://www.thestocktutor.com#thestocktutor -
-
-
-
$CTSO - Heating up..... -
-
-
$CTSO over $6 -
$CTSO on watch -
$CTSO News again -
$CTSO CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U. -
Pre-market Action Plan This Morning:
$MKC long 3pts, ss fail for now$MMM ss 6pts. 165p 100%+$TSLA ss 12pts, support holding$CTSO ss 1pt http://www.spartantrading.com pic.twitter.com/2Vy5UBH8Ij
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.